BIOMAT Database Logo BIOMAT Database Logo

Long-term feeding study of N,N'-diphenyl-p-phenylenediamine in F344 rats. 1989

R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
First Department of Pathology, Nagoya City University Medical School, Japan.

Groups of 50 F344 rats of each sex were fed a diet containing 0.5 or 2% of N,N'-diphenyl-p-phenylenediamine (DPPD) for 104 weeks and were killed 8 weeks after the cessation of DPPD administration. DPPD-treated rats of both sexes showed a dose-dependent reduction in body weight gain, but no lower survival rate, when compared with untreated control rats. Blood and urine analysis showed no remarkable changes due to the treatment. Calcium deposition in the kidney of males was the only significant histological change relating to the treatment. Tumors were found in many organs of all groups, but a significant increase of tumor induction in DPPD-treated groups was not observed.

UI MeSH Term Description Entries
D008297 Male Males
D010655 Phenylenediamines Aniline compounds that contain two amino groups. They are used as a precursor in the synthesis of HETEROCYCLIC COMPOUNDS and POLYMERS. p-Phenylenediamine is used in the manufacture of HAIR DYES and is an ALLERGEN.
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous

Related Publications

R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
[Biological fate of N,N'-diphenyl-p-phenylenediamine].
January 1985, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
Determination of N,N'-diphenyl-p-phenylenediamine in animal tissues.
January 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
Carbon tetrachloride induced liver alterations in rats pretreated with N,N'-diphenyl-p-phenylenediamine.
January 1974, Biochemical pharmacology,
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
Tolerance of the rat for N, N'-diphenyl-p-phenylenediamine.
November 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
Action of N, N'-diphenyl-p-phenylenediamine in tocopherol deficiency diseases.
December 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
Carcinogenicity and toxicity tests on p-phenylenediamine in F344 rats.
May 1983, Toxicology letters,
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
Effect of N-N'-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats.
January 1988, Japanese journal of pharmacology,
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
Anti-uterotropic effect of N,N'-diphenyl-p-phenylenediamine on immature mice.
November 1962, Endocrinology,
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
Modification of chronic carbon tetrachloride hepatic injury by N,N'-diphenyl-p-phenylenediamine.
December 1968, Experimental and molecular pathology,
R Hasegawa, and S Fukushima, and A Hagiwara, and T Masui, and A Masuda, and N Ito
The use of DPPD (N,N'-diphenyl-P-phenylenediamine) as an anti-inflammatory agent.
May 1974, Life sciences,
Copied contents to your clipboard!